Crossmark

Anthrax toxins regulate pain signaling and can deliver molecular cargoes into ANTXR2+ DRG sensory neurons

Crossref DOI link: https://doi.org/10.1038/s41593-021-00973-8

Published Online: 2021-12-20

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Nicole J.

Isensee, Jörg https://orcid.org/0000-0002-3390-0051
Neel, Dylan V.

Quadros, Andreza U.

Zhang, Han-Xiong Bear

Lauzadis, Justas

Liu, Sai Man https://orcid.org/0000-0001-6359-0229
Shiers, Stephanie

Belu, Andreea

Palan, Shilpa

Marlin, Sandra

Maignel, Jacquie

Kennedy-Curran, Angela https://orcid.org/0000-0003-0333-2425
Tong, Victoria S. https://orcid.org/0000-0002-7555-7917
Moayeri, Mahtab

Röderer, Pascal https://orcid.org/0000-0002-1600-1935
Nitzsche, Anja

Lu, Mike

Pentelute, Bradley L. https://orcid.org/0000-0002-7242-801X
Brüstle, Oliver

Tripathi, Vineeta

Foster, Keith A.

Price, Theodore J. https://orcid.org/0000-0002-6971-6221
Collier, R. John

Leppla, Stephen H.

Puopolo, Michelino

Bean, Bruce P.

Cunha, Thiago M.

Hucho, Tim https://orcid.org/0000-0002-4147-9308
Chiu, Isaac M. https://orcid.org/0000-0002-0723-4841
License Information

Text and Data Mining valid from 2021-12-20

Version of Record valid from 2021-12-20
More Information

Article History

Received: 20 June 2020

Accepted: 1 November 2021

First Online: 20 December 2021

Competing interests

: S.M.L., S.P., S.M., J.M., V.T. and K.A.F. are employees of Ipsen. I.M.C. has received sponsored research support from Ipsen, GSK and Allergan Pharmaceuticals, and is a member of scientific advisory boards for GSK and Kintai Pharmaceuticals. This work is related to patent applications PCT/US16/49099 and PCT/US16/49106, ‘Compositions and methods for treatment of pain’, of which R.J.C., I.M.C., B.L.P., K.A.F., S.P. and S.M.L. are co-inventors. O.B. is a co-founder and shareholder of LIFE & BRAIN GmbH. The remaining authors declare no competing interests.

Document is current

Any future updates will be listed below